David B. Weiner - May 13, 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Stock symbol
INO
Transactions as of
May 13, 2021
Transactions value $
-$20,158
Form type
4
Date filed
5/17/2021, 04:27 PM
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +8.7K +1.02% 860K May 14, 2021 Direct F1
transaction INO Common Stock Sale -$20.2K -3.05K -0.35% $6.62* 857K May 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Award $0 +27K $0.00 27K May 13, 2021 Common Stock 27K $6.23 Direct F3, F4
transaction INO Restricted Stock Unit Award $0 +18K $0.00 18K May 13, 2021 Common Stock 18K Direct F3, F5
transaction INO Restricted Stock Unit Options Exercise $0 -8.7K -100% $0.00* 0 May 14, 2021 Common Stock 8.7K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.
F3 This grant was made pursuant to the issuer's non-employee director compensation policy.
F4 Options to vest 100% on May 13, 2022.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.